United States Cystic Fibrosis Drugs Market Report 2017

January 2017 | 118 pages | ID: U434F678C63EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Cystic Fibrosis Drugs

Revenue, means the sales value of Cystic Fibrosis Drugs

This report studies sales (consumption) of Cystic Fibrosis Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Actavis
• F. Hoffmann-La Roche
• Gilead Sciences
• Novartis
• Vertex Pharmaceuticals
• Abbott
• Anthera Pharmaceuticals
• Arcturus Therapeutics
• Boehringer Ingelheim
• Chiesi Farmaceutici
• Corbus Pharmaceuticals
• Genzyme
• Insmed
• Johnson & Johnson
• Merck Sharp & Dohme
• Neovii Biotech
• Novo Nordisk
• PharmaSwiss
• Pharmaxis
• Proteostasis Therapeutics
• PTC Therapeutics
• United Medical
• Venus Remedies

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Oral
• Injection

Split by applications, this report focuses on sales, market share and growth rate of Cystic Fibrosis Drugs in each application, can be divided into

• Hospital
• Clinic

Contents

United States Cystic Fibrosis Drugs Market Report 2017

1 CYSTIC FIBROSIS DRUGS OVERVIEW

1.1 Product Overview and Scope of Cystic Fibrosis Drugs
1.2 Classification of Cystic Fibrosis Drugs
  1.2.1 Oral
  1.2.2 Injection
1.3 Application of Cystic Fibrosis Drugs
  1.3.1 Hospital
  1.3.2 Clinic
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Cystic Fibrosis Drugs (2011-2021)
  1.4.1 United States Cystic Fibrosis Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Cystic Fibrosis Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES CYSTIC FIBROSIS DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Cystic Fibrosis Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Cystic Fibrosis Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Cystic Fibrosis Drugs Average Price by Manufactures (2015 and 2016)
2.4 Cystic Fibrosis Drugs Market Competitive Situation and Trends
  2.4.1 Cystic Fibrosis Drugs Market Concentration Rate
  2.4.2 Cystic Fibrosis Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES CYSTIC FIBROSIS DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Cystic Fibrosis Drugs Sales and Market Share by States (2011-2016)
3.2 United States Cystic Fibrosis Drugs Revenue and Market Share by States (2011-2016)
3.3 United States Cystic Fibrosis Drugs Price by States (2011-2016)

4 UNITED STATES CYSTIC FIBROSIS DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Cystic Fibrosis Drugs Sales and Market Share by Type (2011-2016)
4.2 United States Cystic Fibrosis Drugs Revenue and Market Share by Type (2011-2016)
4.3 United States Cystic Fibrosis Drugs Price by Type (2011-2016)
4.4 United States Cystic Fibrosis Drugs Sales Growth Rate by Type (2011-2016)

5 UNITED STATES CYSTIC FIBROSIS DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Cystic Fibrosis Drugs Sales and Market Share by Application (2011-2016)
5.2 United States Cystic Fibrosis Drugs Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES CYSTIC FIBROSIS DRUGS MANUFACTURERS PROFILES/ANALYSIS

6.1 Actavis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Cystic Fibrosis Drugs Product Type, Application and Specification
    6.1.2.1 Oral
    6.1.2.2 Injection
  6.1.3 Actavis Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 F. Hoffmann-La Roche
  6.2.2 Cystic Fibrosis Drugs Product Type, Application and Specification
    6.2.2.1 Oral
    6.2.2.2 Injection
  6.2.3 F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Gilead Sciences
  6.3.2 Cystic Fibrosis Drugs Product Type, Application and Specification
    6.3.2.1 Oral
    6.3.2.2 Injection
  6.3.3 Gilead Sciences Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Novartis
  6.4.2 Cystic Fibrosis Drugs Product Type, Application and Specification
    6.4.2.1 Oral
    6.4.2.2 Injection
  6.4.3 Novartis Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Vertex Pharmaceuticals
  6.5.2 Cystic Fibrosis Drugs Product Type, Application and Specification
    6.5.2.1 Oral
    6.5.2.2 Injection
  6.5.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Abbott
  6.6.2 Cystic Fibrosis Drugs Product Type, Application and Specification
    6.6.2.1 Oral
    6.6.2.2 Injection
  6.6.3 Abbott Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Anthera Pharmaceuticals
  6.7.2 Cystic Fibrosis Drugs Product Type, Application and Specification
    6.7.2.1 Oral
    6.7.2.2 Injection
  6.7.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Arcturus Therapeutics
  6.8.2 Cystic Fibrosis Drugs Product Type, Application and Specification
    6.8.2.1 Oral
    6.8.2.2 Injection
  6.8.3 Arcturus Therapeutics Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 Boehringer Ingelheim
  6.9.2 Cystic Fibrosis Drugs Product Type, Application and Specification
    6.9.2.1 Oral
    6.9.2.2 Injection
  6.9.3 Boehringer Ingelheim Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 Chiesi Farmaceutici
  6.10.2 Cystic Fibrosis Drugs Product Type, Application and Specification
    6.10.2.1 Oral
    6.10.2.2 Injection
  6.10.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview
6.11 Corbus Pharmaceuticals
6.12 Genzyme
6.13 Insmed
6.14 Johnson & Johnson
6.15 Merck Sharp & Dohme
6.16 Neovii Biotech
6.17 Novo Nordisk
6.18 PharmaSwiss
6.19 Pharmaxis
6.20 Proteostasis Therapeutics
6.21 PTC Therapeutics
6.22 United Medical
6.23 Venus Remedies

7 CYSTIC FIBROSIS DRUGS MANUFACTURING COST ANALYSIS

7.1 Cystic Fibrosis Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cystic Fibrosis Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Cystic Fibrosis Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cystic Fibrosis Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CYSTIC FIBROSIS DRUGS MARKET FORECAST (2016-2021)

11.1 United States Cystic Fibrosis Drugs Sales, Revenue Forecast (2016-2021)
11.2 United States Cystic Fibrosis Drugs Sales Forecast by Type (2016-2021)
11.3 United States Cystic Fibrosis Drugs Sales Forecast by Application (2016-2021)
11.4 Cystic Fibrosis Drugs Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cystic Fibrosis Drugs
Table Classification of Cystic Fibrosis Drugs
Figure United States Sales Market Share of Cystic Fibrosis Drugs by Type in 2015
Figure Oral Picture
Figure Injection Picture
Table Application of Cystic Fibrosis Drugs
Figure United States Sales Market Share of Cystic Fibrosis Drugs by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure United States Cystic Fibrosis Drugs Sales and Growth Rate (2011-2021)
Figure United States Cystic Fibrosis Drugs Revenue and Growth Rate (2011-2021)
Table United States Cystic Fibrosis Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Cystic Fibrosis Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cystic Fibrosis Drugs Sales Share by Manufacturers
Figure 2016 Cystic Fibrosis Drugs Sales Share by Manufacturers
Table United States Cystic Fibrosis Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Cystic Fibrosis Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Cystic Fibrosis Drugs Revenue Share by Manufacturers
Table 2016 United States Cystic Fibrosis Drugs Revenue Share by Manufacturers
Table United States Market Cystic Fibrosis Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Cystic Fibrosis Drugs Average Price of Key Manufacturers in 2015
Figure Cystic Fibrosis Drugs Market Share of Top 3 Manufacturers
Figure Cystic Fibrosis Drugs Market Share of Top 5 Manufacturers
Table United States Cystic Fibrosis Drugs Sales by States (2011-2016)
Table United States Cystic Fibrosis Drugs Sales Share by States (2011-2016)
Figure United States Cystic Fibrosis Drugs Sales Market Share by States in 2015
Table United States Cystic Fibrosis Drugs Revenue and Market Share by States (2011-2016)
Table United States Cystic Fibrosis Drugs Revenue Share by States (2011-2016)
Figure Revenue Market Share of Cystic Fibrosis Drugs by States (2011-2016)
Table United States Cystic Fibrosis Drugs Price by States (2011-2016)
Table United States Cystic Fibrosis Drugs Sales by Type (2011-2016)
Table United States Cystic Fibrosis Drugs Sales Share by Type (2011-2016)
Figure United States Cystic Fibrosis Drugs Sales Market Share by Type in 2015
Table United States Cystic Fibrosis Drugs Revenue and Market Share by Type (2011-2016)
Table United States Cystic Fibrosis Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Cystic Fibrosis Drugs by Type (2011-2016)
Table United States Cystic Fibrosis Drugs Price by Type (2011-2016)
Figure United States Cystic Fibrosis Drugs Sales Growth Rate by Type (2011-2016)
Table United States Cystic Fibrosis Drugs Sales by Application (2011-2016)
Table United States Cystic Fibrosis Drugs Sales Market Share by Application (2011-2016)
Figure United States Cystic Fibrosis Drugs Sales Market Share by Application in 2015
Table United States Cystic Fibrosis Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Cystic Fibrosis Drugs Sales Growth Rate by Application (2011-2016)
Table Actavis Basic Information List
Table Actavis Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Actavis Cystic Fibrosis Drugs Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales Market Share (2011-2016)
Table Gilead Sciences Basic Information List
Table Gilead Sciences Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gilead Sciences Cystic Fibrosis Drugs Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Cystic Fibrosis Drugs Sales Market Share (2011-2016)
Table Vertex Pharmaceuticals Basic Information List
Table Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales Market Share (2011-2016)
Table Abbott Basic Information List
Table Abbott Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Cystic Fibrosis Drugs Sales Market Share (2011-2016)
Table Anthera Pharmaceuticals Basic Information List
Table Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales Market Share (2011-2016)
Table Arcturus Therapeutics Basic Information List
Table Arcturus Therapeutics Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arcturus Therapeutics Cystic Fibrosis Drugs Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Cystic Fibrosis Drugs Sales Market Share (2011-2016)
Table Chiesi Farmaceutici Basic Information List
Table Chiesi Farmaceutici Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Chiesi Farmaceutici Cystic Fibrosis Drugs Sales Market Share (2011-2016)
Table Corbus Pharmaceuticals Basic Information List
Table Genzyme Basic Information List
Table Insmed Basic Information List
Table Johnson & Johnson Basic Information List
Table Merck Sharp & Dohme Basic Information List
Table Neovii Biotech Basic Information List
Table Novo Nordisk Basic Information List
Table PharmaSwiss Basic Information List
Table Pharmaxis Basic Information List
Table Proteostasis Therapeutics Basic Information List
Table PTC Therapeutics Basic Information List
Table United Medical Basic Information List
Table Venus Remedies Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cystic Fibrosis Drugs
Figure Manufacturing Process Analysis of Cystic Fibrosis Drugs
Figure Cystic Fibrosis Drugs Industrial Chain Analysis
Table Raw Materials Sources of Cystic Fibrosis Drugs Major Manufacturers in 2015
Table Major Buyers of Cystic Fibrosis Drugs
Table Distributors/Traders List
Figure United States Cystic Fibrosis Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Cystic Fibrosis Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Cystic Fibrosis Drugs Production Forecast by Type (2016-2021)
Table United States Cystic Fibrosis Drugs Consumption Forecast by Application (2016-2021)
Table United States Cystic Fibrosis Drugs Sales Forecast by States (2016-2021)
Table United States Cystic Fibrosis Drugs Sales Share Forecast by States (2016-2021)